Organ Health Publications
Read Article
Resource Library
Natera Resource Hub - your source for articles and videos.
-
-
ctDNA-based molecular residual disease and survival in resectable colorectal cancer
Nakamura, et al. Nature Medicine 2024
Read Publication
-
Prospera Kidney MD Brochure
Read More
-
Renasight Patient Brochure
Discover how Renasight can provide valuable information about your kindey health.
Read More
-
Have a question or comment?
Contact Us -
Why Prospera Surveillance Brochure
The Prospera non-invasive blood test can comprehensively identify all types of active rejection with great precision.
Read More
-
Elevations of dd-cfDNA before bpAR ProActive Study Publication with Supplement April 2024
Bromberg, et al. Transplantation 2024
Read Publication
-
Renasight Provider Brochure
Learn about Renasight genetic testing and how it can provide valuable information for patient management of kidney disease.
Read More
-
How Dr. Yasir Qazi embraced cell-free DNA surveillance, an unaffected approach due to the recent CMS update
Hear from our ProActive Study Investigator In this episode of our Inside the ProActive Study Podcast, Dr. Yasir Qazi talks to us about: • His dd-cfDNA “surveillance journey” and protocol development.
Watch Video
-
How Dr. Yasir Qazi embraced cell-free DNA surveillance, an unaffected approach due to the recent CMS update - Audio Only
Hear from our ProActive Study Investigator In this episode of our Inside the ProActive Study Podcast, Dr. Yasir Qazi talks to us about his dd-cfDNA “surveillance journey” and protocol development.
Listen Now
-
How Dr. Matthew Cooper leverages dd-cfDNA to replace protocol biopsies for surveillance, in-line with ASTS recommended use
In this episode of our Inside the ProActive Study Podcast, Dr. Matthew Cooper shares his insights on: • Utilizing cfDNA alongside DSA and biopsies before implementing his dd-cfDNA surveillance protoc
Watch Video
-
How Dr. Matthew Cooper leverages dd-cfDNA to replace protocol biopsies for surveillance, in-line with ASTS recommended use
In this episode of our Inside the ProActive Study Podcast, Dr. Matthew Cooper shares his insights on: • Utilizing cfDNA alongside DSA and biopsies before implementing his dd-cfDNA surveillance...
Listen Now
-
How Dr. Millie Samaniego bridged the gap between study use and routine care by extending protocolized use
In this episode of our Inside the ProActive Study Podcast, Dr. Millie Samaniego-Picota tells us about: • Her experience expanding the ProActive Study Protocol schedule to all her patients • How her
Watch Video
-
How Dr. Millie Samaniego bridged the gap between study use and routine care by extending protocolized use
In this episode of our Inside the ProActive Study Podcast, Dr. Millie Samaniego-Picota tells us about: • Her experience expanding the ProActive Study Protocol schedule to all her patients • How her
Listen Now
-
Inside the ProActive Study- How Dr Sanjeev Akkina and Dr. Jessica Coleman approach the continuity of transplant recipient care
Watch Video
-
Inside the ProActive Study- How Dr Sanjeev Akkina and Dr. Jessica Coleman approach the continuity of transplant recipient care podcast
Listen Now
-
How Dr. Anand championed a surveillance protocol informed by his deep experience and research
Watch Video
-
How Dr. Anand championed a surveillance protocol informed by his deep experience and research
Listen Now
-
How Dr. Batarse advocates for his patients upon early recognition of subtle rejection using cfDNA
Watch Video
-
How Dr. Batarse advocates for his patients upon early recognition of subtle rejection using cfDNA
Listen Now
-
ISHLT 2025 - Enhancing overall dd-cfDNA testing accuracy in heart transplantation using fraction and donor quality score(DQS)
Watch Video
-
A Two-Threshold Algorithm using Donor-derived Cell-free DNA Fraction and Quantity to Detect Acute Rejection After Heart Transplantation
Read Publication
-
Duran family's 22q story
The Duran family shares their 22q story, and the importance of early detection and diagnosis.
Watch Video
-
ISHLT 2025- Expanding our Understanding of dd-cfDNA in providing Lung Transplant Personalized Care
Watch Video
-
EMR Integration Benefits to end users
Read More
-
Have a question or comment?
Contact Us -
Recio Study 1 Page
Read More
-
22q11.2 Deletion Syndrome (DiGeorge): Two cases, two outcomes. The importance of prenatal identification
22q11.2 deletion syndrome, also known as DiGeorge, is caused by a missing section of chromosome 22. It is more common than other conditions routinely screened for prenatally such as cystic fibrosis, s
Watch Video
-
Signatera Sample Collection
Watch Video
-
Clinical Conundrum: When cDNA & Biopsy Don't Agree
Watch Video
-
New Data Review Can treating molecular residual disease (MRD) in colorectal cancer improve outcomes
Watch Video
-
KDIGO 2025 ADPKD guideline
Read More
-
Medicare Expands Coverage of Signatera for Patients with Lung Cancer
Read Article
-
A Rare Cancer, A Powerful Tool: What the New Guidelines Mean for Merkel Cell Carcinoma Patients
Read Article
-
How MRD Testing Supports Colorectal Cancer Patients: Jason’s Story and the Importance of Regular Monitoring
Read Article
-
What is the Natera Patient Portal?
Watch Video
-
Does insurance cover the Prospera test?
Watch Video
-
Fetal RhD NIPT Patient Video - Vietnamese
Watch Video
-
Fetal RhD NIPT Patient Video - Spanish
Watch Video
-
Fetal RhD NIPT Patient Video - Russian
Watch Video
-
Fetal RhD NIPT Patient Video - Chinese
Watch Video
-
Loading More...
